Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
21,542
Total Claims
$3.6M
Drug Cost
948
Beneficiaries
$3,821
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-81%
Opioid rate vs peers
0.5% vs 2.6% avg
+258%
Cost per patient vs peers
$3,821 vs $1,068 avg
+11%
Brand preference vs peers
10.0% vs 9.0% avg
Opioid Prescribing
0.5%
Opioid Rate
108
Opioid Claims
$655
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,107 claims · $2.6M
Generic: 19,027 claims · $947K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 202 | $372K |
| Empagliflozin | 139 | $267K |
| Denosumab | 124 | $212K |
| Semaglutide | 78 | $212K |
| Dulaglutide | 72 | $184K |
| Apixaban | 97 | $170K |
| Dapagliflozin Propanediol | 78 | $149K |
| Omega-3 Acid Ethyl Esters | 475 | $141K |
| Telmisartan/Hydrochlorothiazid | 451 | $126K |
| Insulin Lispro | 76 | $123K |
| Insulin Glargine,hum.Rec.Anlog | 93 | $103K |
| Mometasone Furoate | 354 | $96K |
| Lipase/Protease/Amylase | 43 | $89K |
| Lipase/Protease/Amylase | 26 | $86K |
| Icosapent Ethyl | 72 | $82K |
Prescribing Profile
Patient Profile
74
Avg Age
48%
Female
1.56
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data